Human Genome Epidemiology Literature Finder
Records 1 - 17 (of 17 Records) |
Query Trace: Arthritis and DHFR[original query] |
---|
Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis. International journal of molecular medicine 2003 May 11 (5): 593-600. Kumagai Kazuhiko, Hiyama Keiko, Oyama Tetsu, Maeda Hiroyuki, Kohno Nobuo |
Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes. Arthritis and rheumatism 2006 Apr 54 (4): 1087-95. Wessels Judith A M, de Vries-Bouwstra Jeska K, Heijmans Bas T, Slagboom P Eline, Goekoop-Ruiterman Yvonne P M, Allaart Cornelia F, Kerstens Pit J S M, van Zeben Derkjen, Breedveld Ferdinand C, Dijkmans Ben A C, Huizinga Tom W J, Guchelaar Henk-J |
Purine biosynthetic pathway genes and methotrexate response in rheumatoid arthritis patients among north Indians. Pharmacogenetics and genomics 2009 Oct 19 (10): 823-8. Sharma Shruti, Das Mitashree, Kumar Ashok, Marwaha Vishal, Shankar Subramanian, Singh Paramjeet, Raghu Padmanabhan, Aneja Ritu, Grover Rahul, Arya Vivek, Dhir Varun, Gupta Rajiva, Kumar Uma, Juyal Ramesh C, K Thelma |
Dihydrofolate reductase gene intronic 19-bp deletion polymorphisms in a Japanese population. Drug metabolism and pharmacokinetics 2010 25 (5): 516-8. Hayashi Hideki, Horino Masato, Morishita Mariko, Tazoe Yui, Tsuboi Seiji, Matsuyama Taiji, Kosuge Kazuhiro, Yamada Hiroshi, Tsuji Daiki, Inoue Kazuyuki, Itoh Kunihi |
Folate pathway enzyme gene polymorphisms and the efficacy and toxicity of methotrexate in psoriatic arthritis. The Journal of rheumatology 2010 Jul 37 (7): 1508-12. Chandran Vinod, Siannis Fotios, Rahman Proton, Pellett Fawnda J, Farewell Vernon T, Gladman Dafna |
Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis. Pharmacogenomics 2010 Feb 11 (2): 163-75. Kooloos Wouter M, Wessels Judith Am, van der Straaten Tahar, Allaart Cornelia F, Huizinga Tom Wj, Guchelaar Henk-J |
Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients. The pharmacogenomics journal 2012 Mar . Owen SA, Hider SL, Martin P, Bruce IN, Barton A, Thomson W |
Association of dihydrofolate reductase (DHFR) -317AA genotype with poor response to methotrexate in patients with rheumatoid arthritis. Clinical and experimental rheumatology 2012 Feb . Milic V, Jekic B, Lukovic L, Bunjevacki V, Milasin J, Novakovic I, Damnjanovic T, Popovic B, Maksimovic N, Damjanov N, Radunovic G, Pejnovic N, Krajinovic M |
Polymorphisms in genes involved in the mechanism of action of methotrexate: are they associated with outcome in rheumatoid arthritis patients? Pharmacogenomics 2014 Jun 15 (8): 1079-90. Salazar Juliana, Moya Patricia, Altés Albert, Díaz-Torné César, Casademont Jordi, Cerdà-Gabaroi Dacia, Corominas Hèctor, Baiget Montserr |
Genome-wide analysis of methotrexate pharmacogenomics in rheumatoid arthritis shows multiple novel risk variants and leads for TYMS regulation.
![]() Pharmacogenetics and genomics 2014 Apr 24 (4): 211-9. Senapati Sabyasachi, Singh Shalini, Das Mitashree, Kumar Ashok, Gupta Rajiva, Kumar Uma, Jain Sanjay, Juyal Ramesh C, Thelma B |
Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway. European journal of drug metabolism and pharmacokinetics 2015 Jun . Chaabane Souhir, Marzouk Sameh, Akrout Rim, Ben Hamad Mariem, Achour Yosser, Rebai Ahmed, Keskes Leila, Fourati Hela, Bahloul Zouhir, Maalej Abdellat |
Association of 63/91 length polymorphism in the DHFR gene major promoter with toxicity of methotrexate in patients with rheumatoid arthritis. Pharmacogenomics 2016 Sep . Jekic Biljana, Vejnovic Dubravka, Milic Vera, Maksimovic Nela, Damnjanovic Tatjana, Bunjevacki Vera, Novakovic Ivana, Lukovic Ljiljana, Damjanov Nemanja, Krajinovic Ma |
ATIC missense variant affects response to methotrexate treatment in rheumatoid arthritis patients. Pharmacogenomics 2016 Dec 17 (18): 1971-1978. Kurzawski Mateusz, Malinowski Damian, Szarmach Natalia, Nowak Anna, Goryniak Aleksandra, Pawlik Andrzej, Drozdzik Mar |
Association of C35T polymorphism in dihydrofolate reductase gene with toxicity of methotrexate in rheumatoid arthritis patients. Expert opinion on drug metabolism & toxicology 2019 Mar 15 (3): 253-257. Vejnovi? Dubravka, Mili? Vera, Popovi? Branka, Damnjanovi? Tatjana, Maksimovi? Nela, Bunjeva?ki Vera, Krajinovi? Maja, Novakovi? Ivana, Damjanov Nemanja, Jeki? Bilja |
miRNA-24 Gene Sequence, DHFR -829C-T Genotypes, and Methotrexate Response in Mexican Patients with Rheumatoid Arthritis. Genetic testing and molecular biomarkers 2019 Feb . Hernández-Preciado Martha Rocio, Morán-Moguel María Cristina, Dávalos-Rodríguez Ingrid Patricia, Enríquez-Barajas Christian Michel, Valdovinos-Maravilla Juan Paulo, Díaz-Pérez Ana Lilia, Silva-Castro Daniel Efraín, González-López Laura, Gámez-Nava Jorge Ivan, Aceves-Aceves Mario Alberto, Salazar-Páramo Mar |
Pharmacogenetic aspects of methotrexate in a cohort of Colombian patients with rheumatoid arthritis. Biomedical reports 2020 Oct 13 (4): 34. Londono John, Saldarriaga Eugenia-Lucia, Rueda Juan C, Giraldo-Bustos Rodrigo, Angarita Jose-Ignacio, Restrepo Luisa, Ballesteros-Muñoz Jesus, González Camilo, Ospina Maria J, Arias-Correal Sofia, Reyes-Martinez Viviana, Bernalmacias Santiago, Villota-Eraso Catalina, Santos-Moreno Pedro, Martinez-Rodriguez Nancy, Santos Ana |
Identification of SNPs associated with methotrexate treatment outcomes in patients with early rheumatoid arthritis. Frontiers in pharmacology 2022 12 13 1075603. Kolan Shrikant S, Li Gaoyang, Grimolizzi Franco, Sexton Joe, Goll Guro, Kvien Tore K, Sundlisæter Nina Paulshus, Zucknick Manuela, Lillegraven Siri, Haavardsholm Espen A, Skålhegg Bjørn Ste |
- Page last reviewed:Feb 1, 2024
- Content source: